GANX icon

Gain Therapeutics

21 hedge funds and large institutions have $3.74M invested in Gain Therapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$62.6K
2 +$39.9K
3 +$9.91K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$6.72K
5
BlackRock
BlackRock
New York
+$6.51K

Top Sellers

1 -$84.5K
2 -$46.9K
3 -$19.6K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$2K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$923
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.71M
2
$385K
3
$344K
4
$282K
5
$188K
6
$182K
7
$122K
8
$104K
9
$78.2K
10
$75.1K
11
$58.7K
12
$39.9K
13
$39.3K
14
$38.7K
15
$31K
16
$23K
17
$22.8K
18
$11.6K
19
$2.5K
20
$1.56K
21
$37
22
23